NAGE Insider Trading Activity and SEC Form 4 Filings
NAGE insider trading summary
Over the past 12 months, insiders at Niagen Bioscience, Inc. (NAGE) reported 2 open-market purchases worth $46K by 1 insider and no sales on SEC Form 4. Net insider buying was $46K.
Latest NAGE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 14, 2025 | Ozan Pamir | Chief Financial Officer | Buy | $30K (4,464.962 @ $6.81) |
| Nov 14, 2025 | Ozan Pamir | Chief Financial Officer | Buy | $15K (2,220.443 @ $6.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.